Responses
Review
Review
Patent ductus arteriosus: lack of evidence for common treatments
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 22 March 2016
- Published on: 22 March 2016Conservative treatment of symptomatic patent ductus arteriosus beyond the first week of lifeShow More
Bose and Laughon have clearly reviewed the lack of evidence for current treatments of patent ductus arteriosus (PDA) in preterm infants.[1] As highlighted, the general tendency to treat a clinically relevant PDA for fear of adverse clinical outcome with either indomethacin or surgery when indomethacin fails has caused a lack of information on the natural history of symptomatic PDA. Spontaneous PDA closure has been report...
Conflict of Interest:
None declared.